Caprelsa Tablet, Film Coated
Product Images NDC 58468-7840

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Caprelsa (NDC 58468-7840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Caprelsa 01)

Chemical Structure (Caprelsa 01)
Chemical structure diagram of Vandetanib, the active ingredient in CAPRELSA tablets. The diagram shows the molecular arrangement including aromatic rings, heteroatoms, and functional groups characteristic of Vandetanib.*
FDA Label Image

Figure 1 (Caprelsa 02)

Figure 1 (Caprelsa 02)
A Kaplan-Meier survival curve showing progression-free survival over time in months, comparing Caprelsa 300 mg to placebo. The graph includes hazard ratio, confidence interval, and p-value data. A table below the graph shows the number of subjects at risk at different time points for both Caprelsa and placebo groups.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Packaging label for Caprelsa (vandetanib) tablets 100 mg, film-coated oral tablets. The label indicates a package size of 30 tablets and includes branding by Sanofi Genzyme. The label also provides warnings to keep out of reach of children, storage instructions between 68°F and 77°F, and manufacturer information for Genzyme Corporation, Cambridge, MA.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Carton)

Principal Display Panel (100 mg Tablet Bottle Carton)
Packaging label panel for Caprelsa (vandetanib) tablets 300 mg by Genzyme Corporation. The label states 30 tablets per package, Rx only, with storage instructions between 68°F and 77°F. The label also includes the NDC 58468-7840-3, a barcode, and contact information for Genzyme support services.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.